Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 28Colonic Neoplasms 12Rectal Neoplasms 5Recurrence 4Neoplasms 4Esophageal Neoplasms 4Barrett Esophagus 4Stomach Neoplasms 3Gastrointestinal Neoplasms 3Precancerous Conditions 2Pancreatic Neoplasms 2Neoplastic Cells, Circulating 2Neoplasms by Site 2Neoplasm Metastasis 2Intestinal Neoplasms 2Intestinal Diseases 2Digestive System Neoplasms 2Digestive System Diseases 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colonic Diseases 2Cardiovascular Diseases 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Adenoma 2Rectal Diseases 1Prostatic Neoplasms 1Polyps 1Pathologic Processes 1Lynch syndrome I (site-specific colonic cancer) 1Inflammation 1

Interventions

Cetuximab 5Irinotecan 3Gemcitabine 2tivozanib 1neratinib 1lorlatinib 1liposomal doxorubicin 1encorafenib 1binimetinib 1Taxes 1Secretin 1Paclitaxel 1PX-866 1Oxaliplatin 1Lomustine 1Leucovorin 1Fluorouracil 1Doxorubicin 1Carboplatin 1Capecitabine 1CB-839 1CA-19-9 Antigen 1Bevacizumab 1Aspirin 1Albumin-Bound Paclitaxel 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Sensory and Autonomic Neuropathies × Aspirin × Gastrointestinal × Clear all
NCT02467582 2025-05-16

Adjuvant Aspirin Treatment for Colon Cancer Patients

Swiss Cancer Institute

Phase 3 Terminated
1,040 enrolled 11 charts
Gastrointestinal

Colonic Neoplasms, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡